Davern Capital Partners »

Mineralys Therapeutics shares owned by Davern Capital Partners

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Davern Capital Partners from 13F filings

Historical chart of Davern Capital Partners investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Davern Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Davern Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.6M 211k 36.29